Combining quality and innovation: AAA-Pharma starts cooperation with XO Life

Munich, Germany, November 17, 2025 — AAA-Pharma, a company with many years of experience in the generics market, is launching a cooperation with XO Life, an innovative technology company in the healthcare sector. Patients benefit from the high quality standards of AAA-Pharma pharmaceuticals, which are now usefully supplemented by digital support.

Together, the partners are pursuing the goal of not only providing patients with proven generic drugs, but also supporting them through digital therapy support in the areas of metabolism, respiratory health, cardiovascular, mental health and nervous system.

Understanding and managing chronic diseases — with generic drugs and digital support

Many people suffer from conditions such as hypertension, hypercholesterolemia, diabetes mellitus, respiratory diseases, and psychological and neurological stress. Around 425 million people worldwide are affected by diabetes ¹, around one in three adults with high blood pressure and almost 40% of adults with elevated cholesterol levels ². If these diseases are not identified and treated in time, serious sequelae can develop. Despite established therapies and prevention options, there is uncertainty among many people affected as to which measures make individual sense and how a healthy lifestyle can support treatment in the long term.

AAA-Pharma — with a broad portfolio of prescription, high-quality generics — is committed not only to providing patients with high-quality medicines, but also to providing them with guidance in everyday life. Together with XO Life, this care is now supplemented by a digital component: Through the XO Life platform, those affected can document their values, track personal progress and receive individual, guideline-based recommendations as well as access to further information and moderated exchange opportunities with other affected persons — at any time and flexibly.

In this way, AAA-Pharma combines proven generics with innovative digital support — and enables those affected to actively shape their therapy, gain greater safety and sustainably improve their quality of life.

brite™ platform: More safety when dealing with chronic diseases

“Chronic diseases are often associated with uncertainties and gaps in information for those affected,” emphasizes Felix Hollmann, managing director of AAA-Pharma. “With our commitment, we not only want to provide patients with proven generic drugs, but also to support them digitally and thus strengthen their health in the long term. ”

Dr. Friderike Bruchmann, Co-Founder & CEO of XO Life, adds: “Cooperation with AAA-Pharma enables digital support that supports people in everyday life. With brite™, they have access to understandable, scientifically based information and a protected exchange with other affected persons. In this way, we empower patients to make decisions with confidence and to actively take control of their health. ”

Registration is easy via web access or the app for iOS and Android.

‍

About AAA-Pharma

AAA-Pharma GmbH is a family-run pharmaceutical company based in Böblingen near Stuttgart. For over 25 years, the brand has stood for reliable generic drugs and is known as “the yellow brand” among medical professionals. The focus is on a strategy that is clearly based on discount contracts with health insurance companies — for a broad, affordable supply of high-quality medicines throughout Germany. As part of the Wörwag Group, AAA-Pharma combines pharmaceutical expertise with lean structures and a future-oriented view of tomorrow's healthcare. You can find more information at: https://www.aaa-pharma.com/ueber-uns.

‍

About XO Life

XO Life has created a globally unique meta-platform, the brite™ platform, for digital product and therapy support for patients. During their product use or therapy, patients are accompanied with verified medical and health-related content, record their health and treatment history, receive personalized insights and medical support from experts, and can exchange ideas with other patients. 
Manufacturers can open their own product and therapy areas on the 
license the brite™ platform and with your own branding, your own content, 
Make questions and services available to their patients. Through personalized information and continuous support during therapies, manufacturers make an important contribution to treatment success, treatment adherence and application safety for patients.

XO Life is one of the biggest hopefuls in healthcare and is one of the leading digital health scaleups in Germany and Europe. 
XO Life is the market leader in Germany and works with world market leaders 
together with medium-sized German pharmaceutical companies and orphan drug manufacturers. The brite™ platform has recently been offered in all European countries and languages.

More links

Site: www.xo-life.com

LinkedIn: https://www.linkedin.com/company/xo-life

YouTube: https://www.youtube.com/@xo-life/featured

‍

Press contact

XO Life GmbH

Lisa M. Köhler, M.D.

Head of Medical Affairs & Pharmacovigilance

Agnes-Pockels bow 1

80992 Munich

email: pr@xo-life.com

‍

AAA-Pharma GmbH

Nicole Kipping

Digital Marketing Manager

Flugfeld-Allee 24

71034 Boeblingen

email: info@aaa-pharma.com